Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear

Exclusion Criteria

• •Wearing lenses in a monovision modality and is unwilling to be fit with distance lenses in both eyes for the duration of the study. Note: Subjects may not wear lenses in a monovision modality at any time during the study as it will interfere with the visual acuity analysis.
• •Poor personal hygiene.
• •Any active participation in another clinical trial during this trial or within 30 days prior to this study.
• •To the best of the subject's knowledge, she is currently pregnant, is lactating or is planning a pregnancy within the next 3 months.
• •A member, relative or household member of the investigator or of the investigational office staff.
• •Has a known sensitivity to the ingredients used in the Multi-Purpose Disinfection Lens Care System (MPS) approved for use in the study and is unable or unwilling to use the alternate care system.
• •Previous refractive surgery; or current or previous orthokeratology treatment.
• •Is aphakic or pseudophakic.
• •Ocular or systemic disease such as, but not limited to: anterior uveitis or iritis (past or present), glaucoma, Sjögren's syndrome, lupus erythematosus, scleroderma, keratoconus or uncontrolled diabetes.
• •The need for topical ocular medications or any systemic medication which might interfere with contact lens wear or require the lenses to be removed during the day.
• •The presence of clinically significant (grade 2, 3 or 4) anterior segment abnormalities; or the presence of any inflammations such as iritis; or any infection of the eye, lids, or associated structures.
• •A known history of corneal hypoesthesia (reduced corneal sensitivity), corneal ulcer, corneal infiltrates, iritis, bacterial or fungal infections.
• •A history of papillary conjunctivitis that has interfered with contact lens wear.
• •Slit lamp findings that would contraindicate contact lens wear, including but not limited to:
• •* Pathological dry eye or associated dry eye symptoms with decreased tear levels and punctuate staining \> Grade 2
• •* Pterygium
• •* Corneal scars within the visual axis
• •* Neovascularization or ghost vessels \> 1.0 mm in from the limbus
• •* Giant papillary conjunctivitis (GPC) of \> Grade 2
• •* Anterior uveitis or iritis
• •* Seborrheic eczema, seborrheic conjunctivitis or blepharitis